Allied Market Research


Lung Biopsy Devices Market

Lung Biopsy Devices Market Size, Share, Competitive Landscape and Trend Analysis Report by Product Type, by Procedure Type and by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Biopsy is a procedure to perform surgical removal of tissue from an organ to determine the presence or extent of a disease, generally cancerous and inflammatory conditions. Lung biopsyinvolves removal of lung tissues for determining any cancer, infection, or lung disease. Lung biopsy can be performed either by open lung or closed lung procedures. An open lung biopsy is carried out in operating rooms under general anesthesia by making an incision in the skin on the chest and a closed lung biopsy is also called needle biopsy that makes use of a needle for tissue removal. The closed lung biopsy is carried out through skin or trachea. The lung biopsy procedure helps the health professionals to correctly diagnose the suitable treatment for the patient. 

Lung biopsy helps in detecting the stages of cancerin patients;thus, increasing the demand for biopsies across the world as it is an important tool for diagnosis and treatment. Biopsy followed by imaging tests helps in determining whether the nodule is cancerous or non-cancerous. As per WHO, in 2018, lung cancer is responsible for the largest number of deaths approximately 1.8 million deaths across the globe because of the poor prognosis for this cancer. Lower respiratory infections remained the deadliest communicable disease, causing 3.0 million deaths worldwide in 2016.

Rise in prevalence of lung cancer in developing as well as developed countries due to adoption of unhealthy lifestyle along with increase in lung infections are anticipated to boost the demand for lung biopsy systems globally. Furthermore, technological advancements such as ultrasound technology and guidance systems like vacuum assisted guns boost the demand for lung biopsy systems in coming years. However, lack of awareness and high costs associated with lung biopsy systemsare expected to hinder the growth of the lung biopsy devices market. Moreover, risks associated with the biopsy treatment such as lesions and fissure puncturehamper the market growth. On the contrary, introduction of new cost-effective lung biopsy systems and widening base of the population associated with lung cancer are anticipated to provide lucrative opportunities for the growth of the lung biopsy devices market across the globe.

The global lung biopsy devices market is divided on the basis of product, procedure, enduser, and region. Based on product, the market is divided into core needle biopsy devices, fine needle aspiration biopsy devices, surgical biopsy devices, and vacuum-assisted biopsy devices. Based on procedure, it is segmented into needle biopsy, thoracoscopic biopsy, transbronchial biopsy, and open biopsy. By end user, the market is classified into hospitals, cancer research centers, specialty clinics, and others. Region wise, the marketis analyzed across North America, Asia-Pacific, Europe, and LAMEA.

Some of the major players operating in the market are Becton, Dickinson and Company, DTR Medical, Medtronic, Fujifilm Medical Systems, Hologic, Inc., Olympus Corporation, Argon Medical Devices, Argon Medical Devices, Inc., Cardinal Health, Inc., and B. Braun Melsungen AG.

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current market trends and lung biopsy devices market forecast estimations which assists to identify the prevailing opportunities. 

  • An in-depthlung biopsy devices market analysis includes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.

  • A comprehensive analysis of the factors that drive and restrain the growth of the lung biopsy devices market is provided.

  • Region-wise and country-wise market conditions are comprehensively analyzed in this report.

  • The projections in this report are made by analyzing the current lung biopsy devicesmarket trends and future market potential in terms of value.

  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.

  • The key lung biopsy devices market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the lung biopsy devices market.

Lung Biopsy Devices Market Report Highlights

Aspects Details
By Product Type
  • Core Needle Biopsy Devices
  • Fine Needle Aspiration Biopsy Devices
  • Surgical Biopsy Devices
  • Vacuum-Assisted Biopsy Devices
By Procedure Type
  • Needle Biopsy
  • Thoracoscopic Biopsy
  • Transbronchial Biopsy
  • Open Biopsy
By End User
  • Hospitals
  • Cancer Research Centers
  • Specialty Clinics
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players

Medtronic, DTR Medical, Argon Medical Devices, Fujifilm Medical Systems, Argon Medical Devices Inc., Cardinal Health Inc., Hologic Inc., Becton Dickinson and Company, B. Braun Melsungen AG., Olympus Corporation

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Lung Biopsy Devices Market

Global Opportunity Analysis and Industry Forecast, 2023-2032